Anderson, Dr. J Robert

Kimberly McBennett, MD, PhD is a respected specialist and clinical educator specializing in pediatric pulmonary disease at University Hospitals Rainbow Babies & Children’s Hospital in Cleveland, OH. With a focus on adult Cystic Fibrosis, palliative care, and nutrition, Dr. McBennett is board certified in hospice and palliative medicine and internal medicine. Dr. McBennett is actively involved in training fellows in the adult Cystic Fibrosis rotation and plays a key role as a lecturer in the fellowship's core lecture series. Her research primarily centers around the early detection of systemic disease in Cystic Fibrosis patients using MRI, quality improvement initiatives for Cystic Fibrosis, and participation in clinical trials related to the condition. Generated from the website content

James Voos, MD, is a nationally renowned expert in the care of athletes and active patients of all ages. Specializing in sports-related injuries of the knee, shoulder and elbow, he performs a high volume of knee ACL reconstructions, including revision and multi-ligament surgeries, in addition to shoulder and elbow arthroscopy. Dr. Voos has a passion for using his expertise in wearable technology, injury prevention and sports performance to advance the safety and education of athletes. Dr. Voos is board-certified in orthopedic surgery and sports medicine and has a Certificate of Added Qualification (CAQ) in sports medicine. His practice is dedicated to treating athletes from Pee Wee to Pro.

Kevin D. Cooper, MD, is a dermatologist at University Hospitals and Chair of the Department of Dermatology at UH Cleveland Medical Center. He is also the director of the Skin Diseases Research Center at Case Western Reserve University/University Hospitals, focusing on creating advances in skin diseases. As Chair of the department, Dr. Cooper and his team developed a clinical practice with 10 highly integrated dermatology suites throughout the region, all designed with an emphasis on excellence, respect and value. Dr. Cooper is also a co-inventor of the first biologic to be FDA-approved for psoriasis, and co-founded Fluence Therapeutics, a start-up biomedical company created to develop a novel photodynamic therapy for psoriasis and lymphoma.